APLS

Apellis Pharmaceuticals, Inc. Common Stock

$17.25

+0.18 (+1.05%)

Volume:

100 ($1.73K)

#1204 Volume #1645 Dollar Volume

Market Capitalization:

$2.21B

#1842 Market Cap

Apellis Pharmaceuticals Price Chart

Apellis Pharmaceuticals Volume Chart

Apellis Pharmaceuticals Market Segments

Premarket

+0.00(+0.00%)

Open	$17.25
Close	$17.25
Low	$17.25
Low Change	0.00 (0.00%)
High	$17.25
High Change	+0.00 (+0.00%)
Range	$0.00
Volume	100
Dollar Volume	$1.73K

After Hours Yesterday

+0.00(+0.00%)

Open	$17.09
Close	$17.09
Low	$17.09
Low Change	0.00 (0.00%)
High	$17.09
High Change	+0.00 (+0.00%)
Range	$0.00
Volume	5.458K
Dollar Volume	$93.28K

Regular Trading Hours Yesterday

+0.09(+0.53%)

Open	$16.98
Close	$17.07
Low	$16.83
Low Change	-0.15 (-0.88%)
High	$17.27
High Change	+0.29 (+1.68%)
Range	$0.44
Volume	1.585M
Dollar Volume	$27.06M

Premarket Yesterday

+0.13(+0.77%)

Open	$16.98
Close	$17.11
Low	$16.59
Low Change	-0.39 (-2.30%)
High	$17.65
High Change	+0.67 (+3.95%)
Range	$1.06
Volume	6.863K
Dollar Volume	$117.43K

Apellis Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)	$17.33
10 Day Moving Average (SMA10)	$17.60
20 Day Moving Average (SMA20)	$18.57
50 Day Moving Average (SMA50)	$20.68
100 Day Moving Average (SMA100)	$21.66
200 Day Moving Average (SMA200)	$22.39

Apellis Pharmaceuticals Statistics

Average Volume (30 Days)	2.24M
P/E Ratio (Current)	94.28
EPS (Current)	$0.18
Dividend Yield	0.00%
Free Cash Flow	$45.01M
Cash Ratio	1.44
Current Ratio	3.13
Quick Ratio	2.69
Debt to Equity	1.23
Enterprise Value	$2.16B
EV to EBITDA	37.88
EV to Sales	2.15
Price to Book	5.86
Price to Cash Flow	47.86
Price to Free Cash Flow	48.19
Price to Sales	2.16
Return on Assets	0.02%
Return on Equity	0.06%

Apellis Pharmaceuticals Stock Splits

There has been 1 stock split for Apellis Pharmaceuticals (APLS). The reverse stock split occured on March 19, 2004 and reduced the outstanding shares at a ratio of 200:1.

Date	Type	Ratio
Mar 19, 2004	Reverse	200:1

Apellis Pharmaceuticals Dividends

There have been no dividends for Apellis Pharmaceuticals (APLS).